Saleem M, Shoaib M, Yousuf R, Siddiqui F
Sci Rep. 2025; 15(1):7922.
PMID: 40050302
PMC: 11885842.
DOI: 10.1038/s41598-025-91601-z.
Steinbauer S, Wallner M, Karl L, Gramatte T, Essl K, Iken M
Nutrients. 2025; 17(2).
PMID: 39861489
PMC: 11769215.
DOI: 10.3390/nu17020359.
Husain I, Gurley B, Kothapalli H, Wang Y, Della Vedova L, Chittiboyina A
Food Chem (Oxf). 2025; 10():100237.
PMID: 39845339
PMC: 11751564.
DOI: 10.1016/j.fochms.2024.100237.
Santos L, Musther H, Bala N, Deferm N, Patel G, Brouwers J
AAPS J. 2025; 27(1):31.
PMID: 39843813
DOI: 10.1208/s12248-025-01016-x.
Uehara A, Maekawa M, Sakamoto Y, Nakagawa K
Int Microbiol. 2024; .
PMID: 39738815
DOI: 10.1007/s10123-024-00625-4.
Using the Cocrystal Approach as a Promising Drug Delivery System to Enhance the Dissolution and Bioavailability of Formononetin Using an Imidazole Coformer.
Kim J, Lim S, Kim M, Ban E, Kim Y, Kim A
Pharmaceuticals (Basel). 2024; 17(11).
PMID: 39598356
PMC: 11597446.
DOI: 10.3390/ph17111444.
Dual action tofacitinib-loaded PLGA nanoparticles alleviate colitis in an IBD mouse model.
Seegobin N, McCoubrey L, Vignal C, Waxin C, Abdalla Y, Fan Y
Drug Deliv Transl Res. 2024; .
PMID: 39527394
DOI: 10.1007/s13346-024-01736-1.
Engineering a probiotic Bacillus subtilis for acetaldehyde removal: A hag locus integration to robustly express acetaldehyde dehydrogenase.
Hassan-Casarez C, Ryan V, Shuster B, Oliver J, Abbott Z
PLoS One. 2024; 19(11):e0312457.
PMID: 39509360
PMC: 11542774.
DOI: 10.1371/journal.pone.0312457.
Development and Validation of an LC-MS/MS Assay for the Quantitation of MO-OH-Nap Tropolone in Mouse Plasma: Application to In Vitro and In Vivo Pharmacokinetic Studies.
Aldhafiri W, Chhonker Y, Ahmed N, Singh S, Haney S, Ford J
Molecules. 2024; 29(18).
PMID: 39339419
PMC: 11434026.
DOI: 10.3390/molecules29184424.
Oral delivery of stabilized lipid nanoparticles for nucleic acid therapeutics.
Suri K, Pfeifer L, Cvet D, Li A, McCoy M, Singh A
Drug Deliv Transl Res. 2024; .
PMID: 39320435
DOI: 10.1007/s13346-024-01709-4.
Modeling and comparison of dissolution profiles for different brands of albendazole boluses.
Mekasha Y, Mekonen A, Nigussie S, Usure R, Feleke M
BMC Pharmacol Toxicol. 2024; 25(1):48.
PMID: 39123260
PMC: 11316307.
DOI: 10.1186/s40360-024-00774-2.
Oral delivery of nanomedicine for genetic kidney disease.
Huang Y, Wang J, Mancino V, Pham J, OGrady C, Li H
PNAS Nexus. 2024; 3(5):pgae187.
PMID: 38807632
PMC: 11131023.
DOI: 10.1093/pnasnexus/pgae187.
Orally Bioavailable Proteolysis-Targeting Chimeras: An Innovative Approach in the Golden Era of Discovering Small-Molecule Cancer Drugs.
Rej R, Rao Allu S, Roy J, Acharyya R, Kiran I, Addepalli Y
Pharmaceuticals (Basel). 2024; 17(4).
PMID: 38675453
PMC: 11054475.
DOI: 10.3390/ph17040494.
Dissolution Profiles of Immediate Release Products of Various Drugs in Biorelevant Bicarbonate Buffer: Comparison with Compendial Phosphate Buffer.
Okamoto N, Higashino M, Yamamoto H, Sugano K
Pharm Res. 2024; 41(5):959-966.
PMID: 38653942
PMC: 11116250.
DOI: 10.1007/s11095-024-03701-6.
Supramolecular Peptide Self-Assemblies Facilitate Oral Immunization.
Curvino E, Woodruff M, Roe E, Freire Haddad H, Alvarado P, Collier J
ACS Biomater Sci Eng. 2024; 10(5):3041-3056.
PMID: 38623037
PMC: 11382288.
DOI: 10.1021/acsbiomaterials.4c00525.
Model-Informed Drug Development: In Silico Assessment of Drug Bioperformance following Oral and Percutaneous Administration.
Djuris J, Cvijic S, Djekic L
Pharmaceuticals (Basel). 2024; 17(2).
PMID: 38399392
PMC: 10892858.
DOI: 10.3390/ph17020177.
Discriminative Dissolution Method Development Through an aQbD Approach.
Chen H, Wang R, McElderry J
AAPS PharmSciTech. 2023; 24(8):255.
PMID: 38066324
DOI: 10.1208/s12249-023-02692-8.
Excipient Impact on Fenofibrate Equilibrium Solubility in Fasted and Fed Simulated Intestinal Fluids Assessed Using a Design of Experiment Protocol.
Ainousah B, Khadra I, Halbert G
Pharmaceutics. 2023; 15(10).
PMID: 37896244
PMC: 10610309.
DOI: 10.3390/pharmaceutics15102484.
In Vivo Relevance of a Biphasic In Vitro Dissolution Test for the Immediate Release Tablet Formulations of Lamotrigine.
Incecayir T, Demir M
Pharmaceutics. 2023; 15(10).
PMID: 37896234
PMC: 10610453.
DOI: 10.3390/pharmaceutics15102474.
Effect of Food Viscosity on Drug Dissolution.
Hirose R, Sugano K
Pharm Res. 2023; 41(1):105-112.
PMID: 37884679
DOI: 10.1007/s11095-023-03620-y.